Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/27/2000 | CN1278000A Human glucotranferring protein, and coding series thereof |
12/27/2000 | CN1277999A Human cell periodic protein isomer protein, and coding series thereof |
12/27/2000 | CN1277998A Human nitrile hydrolytic enzyme protein and coding series thereof |
12/27/2000 | CN1277997A Glycoprotein relating to human muscle nutrition and coding series therefor |
12/27/2000 | CN1277996A Novel polypeptide-human galactose transferase 40, and polynucleotide for coading same |
12/27/2000 | CN1277995A Novel polypeptide-human cell pigment oxidase related protein 37, and polynucleotide for coding same |
12/27/2000 | CN1277970A Novel polypeptide-human sarcoma protein 20, and polynucleotide for coding same |
12/27/2000 | CN1059929C Human thymosin alpha-source and preparing method thereof |
12/27/2000 | CN1059928C Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus |
12/27/2000 | CN1059927C Reconstituted hepatitis B vaccine with corboxy and having anterior surface antigen 1 determinant |
12/27/2000 | CN1059926C Glucokinase gene and its high expression engineering strain |
12/27/2000 | CN1059923C Detoxicating engineering bacteria and its application |
12/26/2000 | US6166306 Method of producing hybrid catharanthus using male sterility |
12/26/2000 | US6166302 Nucleotide sequence that codes an insecticidal crystal protein; for biological pest control; insecticides |
12/26/2000 | US6166301 Method for assaying genetic attributes in cotton fiber cells |
12/26/2000 | US6166295 Composition and method for plant pathogen resistance |
12/26/2000 | US6166294 Nucleotide sequences which are expressed at preferential time during plant development for more efficient production of plant by-product |
12/26/2000 | US6166293 Method of increasing growth and yield in plants |
12/26/2000 | US6166292 Raffinose synthetase gene, method of producing raffinose and transgenic plant |
12/26/2000 | US6166291 Amplification of disease tolerance to sclerotinia; mating genetically engineered eukaryotic cells coding a preferential oxidase with eukaryotic cells that are disease tolerant, recovering propagants |
12/26/2000 | US6166290 Glutathione-S-conjugate transport in plants |
12/26/2000 | US6166289 IRAK modified transgenic animals |
12/26/2000 | US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor |
12/26/2000 | US6166287 Screening for modulators useful in the treatment of cushing's syndrome and anxiety; administering modulators to transgenic rodent, monitoring expression of protein in preferential hypothalmus cells, compare to wild-type expression |
12/26/2000 | US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense |
12/26/2000 | US6166196 Amplification and detection of Campylobacter jejuni and Campylobacter coli |
12/26/2000 | US6166195 Nucleotide sequences that encode a nematocide |
12/26/2000 | US6166194 Nucleotide sequences coding cancer modulator protein; for gene therapy; antitumor agents |
12/26/2000 | US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy |
12/26/2000 | US6166192 PGC-1, a novel brown fat PPARγ coactivator |
12/26/2000 | US6166191 Nucleotide sequences coding cancer protein; for diagnosis and detection of cell proliferative and developmental defects |
12/26/2000 | US6166186 Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma |
12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
12/26/2000 | US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections |
12/26/2000 | US6166181 Mammalian binding protein; for the treatment of cardiovascular, kidney, brain, psychological and nervous system disorders; antihypoxic agents; hypotensive agents; antiischemic agents |
12/26/2000 | US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein |
12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
12/26/2000 | US6166176 Cancer marker protein and peptides thereof |
12/26/2000 | US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation |
12/26/2000 | US6165992 Histidine kinase |
12/26/2000 | US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae |
12/26/2000 | US6165990 Use of antisense gastrin expression to reduce colon cancer growth |
12/26/2000 | US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence |
12/26/2000 | US6165960 Use of alkaline proteases in industrial textile laundering processes |
12/26/2000 | US6165794 Suppression of proteolytic activity by dysfunctional protease formation |
12/26/2000 | US6165793 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
12/26/2000 | US6165792 Amino acid transporters |
12/26/2000 | US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents |
12/26/2000 | US6165790 Antisense modulation of PI3 kinase p55 gamma expression |
12/26/2000 | US6165789 Antisense modulation of hnRNP A1 expression |
12/26/2000 | US6165787 Regulated transcription of targeted genes and other biological events |
12/26/2000 | US6165786 Antisense modulation of nucleolin expression |
12/26/2000 | US6165782 Nucleotide sequences for the transfer of heterologous nucleotide sequences to cells and biosynthesis of transcripts and heterologous proteins |
12/26/2000 | US6165781 Nucleotide sequences comprising an inverted terminal duplication and heterologous nucleotide sequences; for the treatment of genetic disorders and gene therapy |
12/26/2000 | US6165780 Plasmid for the efficient transformation of seed plants |
12/26/2000 | US6165779 Recombinant virus vector such as tumor suppressor gene formulated in a buffer comprising a detergent; for gene therapy of cancer; buffer comprising a delivery-enhancing agent |
12/26/2000 | US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix |
12/26/2000 | US6165772 Simple and cost-effective preparation of vehicle for delivery of dna, rna, protein, peptide nucleic acids, or lipophilic drugs |
12/26/2000 | US6165771 Compounds |
12/26/2000 | US6165767 Protein phosphatase-related molecules |
12/26/2000 | US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis |
12/26/2000 | US6165765 Heat resistant enzyme from bacillus; for more accurate sequence determination using chain terminating nucleotides |
12/26/2000 | US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides |
12/26/2000 | US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections |
12/26/2000 | US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections |
12/26/2000 | US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators |
12/26/2000 | US6165756 Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine |
12/26/2000 | US6165755 Chicken neuropeptide gene useful for improved poultry production |
12/26/2000 | US6165754 Method of expressing an exogenous nucleic acid |
12/26/2000 | US6165753 Cyclin E genes and proteins |
12/26/2000 | US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents |
12/26/2000 | US6165751 HLDAT86 polynucleotides |
12/26/2000 | US6165750 Streptavidin tetramers have at least one monomer containing an amino acid modification that produces a reduced binding affinity for biotin, a modified off-rate, a modified on-rate, or an altered binding enthalpy; bioseparations, drug delivery |
12/26/2000 | US6165749 Plasmid vector comprising promoter sequence to control expression of desired gene, said promoter sequence being recognized by rna polymerase derived from sp6 phage, and a replication origin for increasing copy number by induction |
12/26/2000 | US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs |
12/26/2000 | US6165747 Comprise morphogenic signals produced by tissue patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates |
12/26/2000 | US6165746 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
12/26/2000 | US6165744 Isolation and characterization of cDNAs coding for the α, β, and γ subunits of the high-affinity receptor for immunoglobulin E |
12/26/2000 | US6165738 Hybrid of two human isoforms; for recombinant production; for diagnosis, presymptomatic detection, and prevention of insulin dependent diabetes mellitus |
12/26/2000 | US6165737 Screening modulators of human dff40 activity by contacting cell expressing recombinant, human dff40/dff45 complex with candidate; activating factor; and comparing apoptosis with or without candidate |
12/26/2000 | US6165735 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
12/26/2000 | US6165733 γ II adaptin |
12/26/2000 | US6165728 Nucleotide sequences which hybridize to gene and inhibit gene expression of human adaptor protein involved in signal transduction; diagnosis, therapy, and prophylaxis of related diseases |
12/26/2000 | US6165727 Analyzing the dna sequence of angiotensinogen gene for a mutation which is in linkage disequilibrium with mutation m235t; presence indicates predisposition |
12/26/2000 | US6165724 Oligonucleotides for detecting enteric hemorrhagic E.coli and detection method using the same |
12/26/2000 | US6165722 Representations of bimolecular interactions |
12/26/2000 | US6165721 Oligonucleotides of specific nucleotide sequences; for strand displacement amplification; for hybridization probes |
12/26/2000 | US6165720 Conjugating nucleic acid with a peptide nucleic acid in a sequence-specific manner prior to transfection, transfecting cell with conjugate, and monitoring intracellular location |
12/26/2000 | US6165719 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
12/26/2000 | US6165718 Method for in vivo production of a mutant library in cells |
12/26/2000 | US6165717 Method of synthesizing diverse collections of oligomers |
12/26/2000 | US6165716 Diagnosis of migraine, bipolar disorder, unipolar depression, or susceptibility in human by sampling nucleic acids and analyzing number of copies of variable number tandem repeat region in the second intron of serotonin transporter gene |
12/26/2000 | US6165715 Expression systems |
12/26/2000 | US6165714 Devices and methods for detecting nucleic acid analytes in samples |
12/26/2000 | US6165713 Composition and methods relating to DNA mismatch repair genes |
12/26/2000 | US6165712 Contacting a cell with an exogenous molecule effective to modulate gene expression and affect level of protein thus pathological effect; molecule binds to regulatory sequence, rna, or transcription regulating protein; viricides |
12/26/2000 | US6165711 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality |
12/26/2000 | US6165709 Rapid and less expensive method by identifying cellular constituents as perturbed or not perturbed when exposed to drug |
12/26/2000 | US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide |
12/26/2000 | US6165476 Fusion proteins with an immunoglobulin hinge region linker |